BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18294286)

  • 1. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.
    Chuang MJ; Sun KH; Tang SJ; Deng MW; Wu YH; Sung JS; Cha TL; Sun GH
    Cancer Sci; 2008 May; 99(5):905-13. PubMed ID: 18294286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
    Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
    Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
    J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobalt Chloride-induced Hypoxia Induces Epithelial-mesenchymal Transition in Renal Carcinoma Cell Lines.
    Zhang N; Hong B; Zhou C; Du X; Chen S; Deng X; Duoerkun S; Li Q; Yang Y; Gong K
    Ann Clin Lab Sci; 2017 Jan; 47(1):40-46. PubMed ID: 28249915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β.
    Petrella BL; Vincenti MP
    Cancer Med; 2012 Aug; 1(1):17-27. PubMed ID: 23342250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mukai M; Okada Y
    Lab Invest; 2011 Oct; 91(10):1443-58. PubMed ID: 21808237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
    Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
    Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
    Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
    Koo AS; Armstrong C; Bochner B; Shimabukuro T; Tso CL; deKernion JB; Belldegrum A
    Cancer Immunol Immunother; 1992; 35(2):97-105. PubMed ID: 1596939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway.
    Liu XR; Li SF; Mei WY; Liu XD; Zhou RB
    Chin J Integr Med; 2024 Apr; 30(4):299-310. PubMed ID: 38212502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
    König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
    Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.
    Falkensammer C; Jöhrer K; Gander H; Ramoner R; Putz T; Rahm A; Greil R; Bartsch G; Thurnher M
    Cancer Immunol Immunother; 2006 Oct; 55(10):1228-37. PubMed ID: 16810557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
    Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
    Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.